Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07831889) titled 'Hypofractionated Radiotherapy After Breast Reconstruction for Breast Cancer' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
Condition:
Breast Cancer
Intervention:
Radiation: Whole-dose radiotherapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2026
Target Sample Size: 960
To know more, visit https://clinicaltrials.gov/study/NCT07831889
Published by HT Digital Conten...